Anzeige
Mehr »
Login
Montag, 09.12.2024 Börsentäglich über 12.000 News von 682 internationalen Medien
Dieses Unternehmen wird das MicroStrategy von SOLANA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
436 Leser
Artikel bewerten:
(1)

HSARx Partners with Two General Agencies to Offer Prescription Savings through Insurance Broker Networks

Finanznachrichten News

Offering Broker Commissions, HSARx Rapidly Expands U.S. Footprint

LAS VEGAS, NV / ACCESSWIRE / October 4, 2022 / HSARx - launched in August 2022 and offering traditional pharmacy benefit management savings directly to health savings account subscribers - announced today that it has partnered with two general agencies in Arizona to expand the reach of its offerings.

HSARx, Tuesday, October 4, 2022, Press release picture

The agencies include Paragon Partners and Arizona Benefit Administrators, which encompass over 300 brokers throughout Arizona and the United States. As part of their agreement with HSARx, these general agencies and their brokers - among existing and future partners - will receive a commission payment on each prescription filled through the program.

HSARx is available to all consumers and can equate to significant savings compared to existing competitors, with no coupons or gimmicks needed. With HSARx, consumers may use pre-tax HSA dollars or a personal debit or credit card to pay for their medicine, all while saving 40 to 80% on all levels of medications. By integrating directly into consumers HSA account or debit/credit card, HSARx offers the consumer all the benefits and cost savings that have been available traditionally to large health insurance companies.

"On the heels of our recent launch, the buzz surrounding our broker commission model and consumer savings has been very strong," said Dennis Sponer, CEO of HSARx. "We're grateful to have these two general agencies on board and look forward to growing together in the times ahead."

In terms of related data, approximately $75 billion in health care dollars fall under the management of HSAs. Growth in the sector is increasing at a rate of 19% per year. Approximately 13% of Americans lost their prescription drug coverage from their health insurer in 2020 and 28% of Americans take at least one prescription that is not covered by their health insurance.

For more information on HSARx, visit www.HSARx.com or call 888-472-7912.

If you are an Agency and would like more information about partnering with HSARx, please email sales@hsarx.com or call 1-888-472-7912 to be referred to the sales department.

About HSARx
With better consumer savings and being easier to use, HSARx has developed a revolutionary new product previously unseen in the healthcare marketplace. Launched in 2022, HSARx enables consumers to pay for and obtain discounts on prescription medications while automatically billing their health savings account or credit/debit account without an HSA account. This program saves individuals up to 80% on their out-of-pocket drug spending, providing access to discounts traditionally only available to large insurance companies. For more information, visit the company's website at www.HSARx.com.

###

Media Contacts:
For HSARx - The Firm Public Relations & Marketing - 702.739.9933

Jasen Woehrle/ ext. 234/ jasenw@thefirmpr.com

Jesse Scott/ ext. 228/ jscott@thefirmpr.com

SOURCE: HSARx



View source version on accesswire.com:
https://www.accesswire.com/718689/HSARx-Partners-with-Two-General-Agencies-to-Offer-Prescription-Savings-through-Insurance-Broker-Networks

© 2022 ACCESSWIRE
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.